Context Therapeutics Inc. (CNTX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- None
- No Form 4 sale on record
- Form 4 sales
- 0
- On record
- Form 144 notices
- 0
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
No Form 4 sale on record.
Timeline
No filings yet.
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 26, 2026 | CNTX | Pasternak Andy | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| Jun 24, 2026 | Jun 26, 2026 | CNTX | Stacey Jennifer Evans | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| Jun 24, 2026 | Jun 26, 2026 | CNTX | West Linda | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| Jun 24, 2026 | Jun 26, 2026 | CNTX | Smith Karen L. | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| Jun 24, 2026 | Jun 26, 2026 | CNTX | Walker Luke Nathaniel | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| Jun 24, 2026 | Jun 26, 2026 | CNTX | Kantoff Philip W. | Director | AwardedStock Option (right to buy) | 45,000 | 45,000 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | CNTX | Levit Alex C. | Chief Legal Officer, Corp. Sec | AwardedStock Option (right to buy) | 270,000 | 270,000 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | AwardedStock Option (right to buy) | 275,000 | 275,000 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | CNTX | Chagin Karen Deborah | Chief Medical Officer | AwardedStock Option (right to buy) | 290,000 | 290,000 | SEC | ||
| Feb 19, 2026 | Feb 23, 2026 | CNTX | Lehr Martin A. | Chief Executive Officer | AwardedStock Option (right to buy) | 815,000 | 815,000 | SEC | ||
| Jun 12, 2025 | Jun 12, 2025 | CNTX | Pasternak Andy | Director | AwardedStock Option (right to buy) | 138,900 | 138,900 | SEC | ||
| Jun 12, 2025 | Jun 12, 2025 | CNTX | Kantoff Philip W. | Director | AwardedStock Option (right to buy) | 123,500 | 123,500 | SEC | ||
| Jun 12, 2025 | Jun 12, 2025 | CNTX | Smith Karen L. | Director | AwardedStock Option (right to buy) | 123,500 | 123,500 | SEC | ||
| Jun 12, 2025 | Jun 12, 2025 | CNTX | Stacey Jennifer Evans | Director | AwardedStock Option (right to buy) | 123,500 | 123,500 | SEC | ||
| Jun 12, 2025 | Jun 12, 2025 | CNTX | Walker Luke Nathaniel | Director | AwardedStock Option (right to buy) | 123,500 | 123,500 | SEC | ||
| Jun 12, 2025 | Jun 12, 2025 | CNTX | West Linda | Director | AwardedStock Option (right to buy) | 123,500 | 123,500 | SEC | ||
| Jun 9, 2025 | Jun 10, 2025 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 100,000 | $0.70 | $70k | 920,190 | SEC |
| Jun 9, 2025 | Jun 9, 2025 | CNTX | Chagin Karen Deborah | Chief Medical Officer | AwardedStock Option (right to buy) | 153,000 | 153,000 | SEC | ||
| Jun 6, 2025 | Jun 10, 2025 | CNTX | Levit Alex C. | Chief Legal Officer, Corp. Sec | Bought | 20,000 | $0.58 | $12k | 29,000 | SEC |
| Jun 6, 2025 | Jun 10, 2025 | CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | Bought | 40,010 | $0.64 | $26k | 80,010 | SEC |
| Feb 13, 2025 | Feb 14, 2025 | CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | AwardedStock Option (right to buy) | 371,800 | 371,800 | SEC | ||
| Feb 13, 2025 | Feb 14, 2025 | CNTX | Levit Alex C. | Chief Legal Officer, Corp. Sec | AwardedStock Option (right to buy) | 349,900 | 349,900 | SEC | ||
| Feb 13, 2025 | Feb 14, 2025 | CNTX | Dansky Ullmann Claudio | Chief Medical Officer | AwardedStock Option (right to buy) | 174,960 | 174,960 | SEC | ||
| Feb 13, 2025 | Feb 14, 2025 | CNTX | Lehr Martin A. | Chief Executive Officer | AwardedStock Option (right to buy) | 802,700 | 802,700 | SEC | ||
| Jan 13, 2025 | Jan 14, 2025 | CNTX | Pasternak Andy | Director | AwardedStock Option (right to buy) | 20,685 | 20,685 | SEC | ||
| Sep 4, 2024 | Sep 5, 2024 | CNTX | Smith Karen L. | Director | AwardedStock Option (right to buy) | 19,315 | 19,315 | SEC | ||
| Sep 4, 2024 | Sep 5, 2024 | CNTX | Walker Luke Nathaniel | Director | AwardedStock Option (right to buy) | 19,315 | 19,315 | SEC | ||
| Aug 1, 2024 | Aug 1, 2024 | CNTX | Dansky Ullmann Claudio | Chief Medical Officer | AwardedStock Option (right to buy) | 202,170 | 202,170 | SEC | ||
| Jun 13, 2024 | Jun 14, 2024 | CNTX | Stacey Jennifer Evans | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| Jun 13, 2024 | Jun 14, 2024 | CNTX | Kantoff Philip W. | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| Jun 13, 2024 | Jun 14, 2024 | CNTX | West Linda | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| Jun 13, 2024 | Jun 14, 2024 | CNTX | Berman Richard J | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Mar 21, 2024 | Mar 22, 2024 | CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | AwardedStock Option (right to buy) | 160,115 | 160,115 | SEC | ||
| Mar 21, 2024 | Mar 22, 2024 | CNTX | Levit Alex C. | Chief Legal Officer, Corp. Sec | AwardedStock Option (right to buy) | 153,515 | 153,515 | SEC | ||
| Mar 21, 2024 | Mar 22, 2024 | CNTX | Lehr Martin A. | Chief Executive Officer | AwardedStock Option (right to buy) | 291,402 | 291,402 | SEC | ||
| May 31, 2023 | May 31, 2023 | CNTX | Kantoff Philip W. | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| May 31, 2023 | May 31, 2023 | CNTX | West Linda | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| May 31, 2023 | May 31, 2023 | CNTX | Stacey Jennifer Evans | Director | AwardedStock Option (right to buy) | 25,000 | 25,000 | SEC | ||
| May 31, 2023 | May 31, 2023 | CNTX | Berman Richard J | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Feb 21, 2023 | Feb 21, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 5,823 | $0.84 | $5k | 159,701 | SEC |
| Feb 13, 2023 | Feb 14, 2023 | CNTX | Levit Alex C. | Chief Legal Officer, Corp. Sec | AwardedStock Option (right to buy) | 151,505 | 151,505 | SEC | ||
| Feb 13, 2023 | Feb 14, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | AwardedStock Option (right to buy) | 287,544 | 287,544 | SEC | ||
| Feb 13, 2023 | Feb 14, 2023 | CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | AwardedStock Option (right to buy) | 158,001 | 158,001 | SEC | ||
| Feb 13, 2023 | Feb 13, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 5,606 | $0.87 | $5k | 153,878 | SEC |
| Feb 6, 2023 | Feb 6, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 5,040 | $0.97 | $5k | 148,272 | SEC |
| Jan 30, 2023 | Jan 30, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 7,027 | $0.70 | $5k | 143,232 | SEC |
| Jan 23, 2023 | Jan 23, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 6,839 | $0.72 | $5k | 136,205 | SEC |
| Jan 17, 2023 | Jan 18, 2023 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 6,783 | $0.74 | $5k | 129,366 | SEC |
| Dec 16, 2022 | Dec 19, 2022 | CNTX | Minai-Azary Jennifer Lynn | Chief Financial Officer | Bought | 25,000 | $0.74 | $19k | 40,000 | SEC |
| Dec 16, 2022 | Dec 19, 2022 | CNTX | Lehr Martin A. | Chief Executive Officer | Bought | 20,000 | $0.74 | $15k | 122,583 | SEC |
Page 1